A Procedure for Dna Methylation Assessment in Osteoporosis-Related Gene Promoters of Umbilical Cord Blood: A Study on the Prospective Epidemiological Research Studies in Iran (Persian) Birth Cohort Publisher

Summary: A study shows DNA markers in newborns’ cord blood may help predict risk of bone weakness later in life. This could open doors for earlier prevention. #Osteoporosis #Epigenetics

Mahdavi SB^{1, 2, 3} ; Javadirad SM⁴ ; Rafieian M^{2, 3} ; Poursafa P² ; Zavareh VA³ ; Daniali SS² ; Heidaribeni M² ; Goodarzikhoigani M² ; Vahdatpour B¹ ; Mirhendi H^{3, 5} ; Kelishadi R²
Source: BioImpacts Published:2025

Abstract

Introduction: It is believed that DNA methylation can modify disease susceptibility in response to environmental factors as early as the perinatal period. In this study, we aimed to present a streamlined DNA methylation analysis procedure for osteoporosis-related gene promoters in the umbilical cord blood. Methods: The Prospective Epidemiological Research Studies in Iran (PERSIAN) birth cohort was established in 2016. In this study, a total of 300 umbilical cord blood samples were collected at the time of delivery. For all samples, DNA was extracted and converted using sodium bisulfite. Multiple primer sets were designed for Wnt1, Wnt10b, β-catenin, OPG, and RANKL gene promoters in the online MethPrimer platform. Next, bisulfite sequencing PCR (BSP), as the gold standard method for exploring methylated and unmethylated cytosines, was performed in a gradient-controlled setting. The PCR products were then purified and directly sequenced. Subsequently, the chromatograms were interpreted. Results: For Wnt10b, β-catenin, and OPG genes, the converted DNA could be successfully amplified. The frequency of acceptable chromatograms for analysis was 195 for Wnt10b (195/300, 0.65%), 198 for β-catenin (198/300, 0.66%), and 50 for OPG (50/50, 100%). Conclusion: BSP can be efficiently used to investigate the methylation of target gene promoters in umbilical cord blood DNA. © 2025 The Author(s).